• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒驱动的黏膜免疫调节及其与微生物群的相互作用

Nanoparticle-Driven Modulation of Mucosal Immunity and Interplay with the Microbiome.

作者信息

Jung Won, Son Young Min

机构信息

Department of Systems Biotechnology, Chung-Ang University, Anseong-si 17546, Republic of Korea.

出版信息

J Microbiol Biotechnol. 2025 Jun 12;35:e2404033. doi: 10.4014/jmb.2504.04033.

DOI:10.4014/jmb.2504.04033
PMID:40537897
Abstract

Mucosal surfaces are dynamic immunological interfaces that play a critical role in maintaining host defense and microbial homeostasis. Disruptions in the interaction between the mucosal immune system and its commensal microbiota have been associated with the onset of several diseases, including inflammatory bowel disease, asthma, and bacterial vaginosis. This review examines recent advances in nanoparticle (NP)-based strategies aimed at modulating mucosal immunity and restructuring microbial communities. It highlights how organic and inorganic NPs such as polysaccharide-based carriers, lipid NPs, and metallic nanomaterials enhance the delivery and stability of probiotics, prebiotics, and synbiotics, and facilitate targeted immunomodulation across gastrointestinal, respiratory, and female reproductive mucosal tissues. NP-based strategies are particularly emphasized for their ability to penetrate mucus barriers, facilitate microbial colonization, modulate cytokine activity, and enhance the restoration of epithelial barrier function. Disease-specific applications, including NP-based therapies for colitis, respiratory inflammation, and vaginal dysbiosis, are also discussed. In addition, this review outlines current challenges related to biosafety, targeting specificity, and clinical translation, and suggests future directions for research. Altogether, NP platforms offer a promising avenue for the precise modulation of mucosal immunity and microbiota, with significant potential in the prevention and treatment of mucosal-associated diseases.

摘要

黏膜表面是动态的免疫界面,在维持宿主防御和微生物稳态方面发挥着关键作用。黏膜免疫系统与其共生微生物群之间相互作用的破坏与多种疾病的发生有关,包括炎症性肠病、哮喘和细菌性阴道病。本综述探讨了基于纳米颗粒(NP)的策略在调节黏膜免疫和重塑微生物群落方面的最新进展。它强调了有机和无机NP,如多糖基载体、脂质NP和金属纳米材料,如何增强益生菌、益生元及合生元的递送和稳定性,并促进跨胃肠道、呼吸道和女性生殖黏膜组织的靶向免疫调节。基于NP的策略因其穿透黏液屏障、促进微生物定植、调节细胞因子活性以及增强上皮屏障功能恢复的能力而受到特别强调。还讨论了特定疾病的应用,包括基于NP的结肠炎、呼吸道炎症和阴道生态失调治疗方法。此外,本综述概述了与生物安全性、靶向特异性和临床转化相关的当前挑战,并提出了未来的研究方向。总之,NP平台为精确调节黏膜免疫和微生物群提供了一条有前景的途径,在预防和治疗黏膜相关疾病方面具有巨大潜力。

相似文献

1
Nanoparticle-Driven Modulation of Mucosal Immunity and Interplay with the Microbiome.纳米颗粒驱动的黏膜免疫调节及其与微生物群的相互作用
J Microbiol Biotechnol. 2025 Jun 12;35:e2404033. doi: 10.4014/jmb.2504.04033.
2
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
3
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
4
Probiotics in infants for prevention of allergic disease.婴儿使用益生菌预防过敏性疾病。
Cochrane Database Syst Rev. 2025 Jun 13;6(6):CD006475. doi: 10.1002/14651858.CD006475.pub3.
5
Exploring the gut microbiome's influence on cancer-associated anemia: Mechanisms, clinical challenges, and innovative therapies.探索肠道微生物群对癌症相关性贫血的影响:机制、临床挑战及创新疗法。
World J Gastrointest Pharmacol Ther. 2025 Jun 5;16(2):105375. doi: 10.4292/wjgpt.v16.i2.105375.
6
Kidney-Gut Axis in Chronic Kidney Disease: Therapeutic Perspectives from Microbiota Modulation and Nutrition.慢性肾脏病中的肾-肠轴:微生物群调节与营养的治疗前景
Nutrients. 2025 Jun 9;17(12):1961. doi: 10.3390/nu17121961.
7
Probiotics, prebiotics, synbiotics, and fecal microbiota transplantation in the treatment of behavioral symptoms of autism spectrum disorder: A systematic review.益生菌、益生元、合生菌和粪便微生物群移植治疗自闭症谱系障碍的行为症状:系统评价。
Autism Res. 2021 Sep;14(9):1820-1836. doi: 10.1002/aur.2560. Epub 2021 Jun 26.
8
Probiotics for management of functional abdominal pain disorders in children.益生菌治疗儿童功能性腹痛疾病。
Cochrane Database Syst Rev. 2023 Feb 17;2(2):CD012849. doi: 10.1002/14651858.CD012849.pub2.
9
The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.益生菌、益生元、合生菌和粪便微生物群移植治疗肠易激综合征的疗效:系统评价和网络荟萃分析。
Nutrients. 2024 Jul 2;16(13):2114. doi: 10.3390/nu16132114.
10
Being a better version of yourself: genetically engineered probiotic bacteria as host defense enhancers in the control of intestinal pathogens.成为更好的自己:基因工程益生菌作为宿主防御增强剂用于控制肠道病原体
Gut Microbes. 2025 Dec;17(1):2519696. doi: 10.1080/19490976.2025.2519696. Epub 2025 Jun 18.

本文引用的文献

1
Polysaccharide nanoparticles as potential immune adjuvants: Mechanism and function.多糖纳米颗粒作为潜在的免疫佐剂:作用机制与功能
Acta Pharm Sin B. 2025 Apr;15(4):1796-1815. doi: 10.1016/j.apsb.2025.03.006. Epub 2025 Mar 7.
2
Protein-based molecular imprinting: gelatin nanotraps for interleukin-6 sequestration in inflammation cell models.基于蛋白质的分子印迹:用于炎症细胞模型中白细胞介素-6隔离的明胶纳米陷阱
Trends Biotechnol. 2025 May;43(5):1215-1233. doi: 10.1016/j.tibtech.2025.02.002. Epub 2025 Mar 6.
3
Advances in bio-polymer coatings for probiotic microencapsulation: chitosan and beyond for enhanced stability and controlled release.
用于益生菌微胶囊化的生物聚合物涂层的进展:壳聚糖及其他用于增强稳定性和控制释放的材料
Des Monomers Polym. 2024 Dec 31;28(1):1-34. doi: 10.1080/15685551.2024.2448122. eCollection 2025.
4
Regulation of dynamic spatiotemporal inflammation by nanomaterials in spinal cord injury.纳米材料对脊髓损伤中动态时空炎症的调节作用
J Nanobiotechnology. 2024 Dec 19;22(1):767. doi: 10.1186/s12951-024-03037-8.
5
Chitosan-coated probiotic nanoparticles mitigate acrylamide-induced toxicity in the Drosophila model.壳聚糖包被益生菌纳米颗粒减轻丙烯酰胺诱导的果蝇模型毒性。
Sci Rep. 2024 Sep 11;14(1):21182. doi: 10.1038/s41598-024-72200-w.
6
Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine.吸入疗法中基于纳米颗粒的药物递送系统:改善呼吸医学。
Pharmaceuticals (Basel). 2024 Aug 12;17(8):1059. doi: 10.3390/ph17081059.
7
Advances in silver nanoparticles: a comprehensive review on their potential as antimicrobial agents and their mechanisms of action elucidated by proteomics.银纳米颗粒的研究进展:关于其作为抗菌剂的潜力及其蛋白质组学阐明的作用机制的全面综述
Front Microbiol. 2024 Jul 31;15:1440065. doi: 10.3389/fmicb.2024.1440065. eCollection 2024.
8
Probiotics for the Prevention of Vaginal Infections: A Systematic Review.益生菌预防阴道感染:一项系统评价。
Cureus. 2024 Jul 13;16(7):e64473. doi: 10.7759/cureus.64473. eCollection 2024 Jul.
9
Anti-inflammatory action of silver nanoparticles : systematic review and meta-analysis.银纳米颗粒的抗炎作用:系统评价与荟萃分析
Heliyon. 2024 Jul 14;10(14):e34564. doi: 10.1016/j.heliyon.2024.e34564. eCollection 2024 Jul 30.
10
Pulmonary delivery of silver nanoparticles prevents influenza infection by recruiting and activating lymphoid cells.肺部递送银纳米颗粒通过募集和激活淋巴细胞来预防流感感染。
Biomaterials. 2025 Jan;312:122721. doi: 10.1016/j.biomaterials.2024.122721. Epub 2024 Jul 29.